• Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints

FDA advisers pan Pfizer’s PARP drug; Sarepta to resume Duchenne study

Simon Osuji by Simon Osuji
May 23, 2025
in Technology
0
Akeso claims another PD-1/VEGF win; FDA requests more data from Novavax
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K. regulators cleared Sarepta to restart an Elevidys study and Altos Labs bought a startup.

Related posts

FDA rejects Regenxbio treatment in another blow to gene therapy

FDA clears repurposed GSK drug for ultra-rare brain disease instead of autism

March 11, 2026
Mozambique struggles to turn vast gas wealth into sustainable development – EnviroNews

Mozambique struggles to turn vast gas wealth into sustainable development – EnviroNews

March 11, 2026

Source link

Previous Post

Africa Energy Technology Conference Provides a Platform for Fostering Innovation

 Next Post

How Illegal Dumping Affects South Africa’s Rivers
Next Post
How Illegal Dumping Affects South Africa’s Rivers

How Illegal Dumping Affects South Africa’s Rivers

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

Trump’s asylum offer sparks interest as thousands of South Africans apply

Trump’s asylum offer sparks interest as thousands of South Africans apply

12 months ago
Why is XRP Struggling Despite SEC Nod for Hashdex Nasdaq ETF

Why is XRP Struggling Despite SEC Nod for Hashdex Nasdaq ETF

6 months ago
BRICS-aligned African countries face rising risk as Trump unveils new tariff agenda

BRICS-aligned African countries face rising risk as Trump unveils new tariff agenda

8 months ago
Why Nevada casinos won’t use a new gun-detection system being used in other states

Why Nevada casinos won’t use a new gun-detection system being used in other states

1 year ago

POPULAR NEWS

  • Mahama attends Liberia’s 178th independence anniversary

    Mahama attends Liberia’s 178th independence anniversary

    0 shares
    Share 0 Tweet 0

  • Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    0 shares
    Share 0 Tweet 0

  • The world’s top 10 most valuable car brands in 2025

    0 shares
    Share 0 Tweet 0

  • Top 10 African countries with the highest GDP per capita in 2025

    0 shares
    Share 0 Tweet 0

  • Global ranking of Top 5 smartphone brands in Q3, 2024

    0 shares
    Share 0 Tweet 0

Get strategic intelligence you won’t find anywhere else. Subscribe to the Limitless Beliefs Newsletter for monthly insights on overlooked business opportunities across Africa.

Subscription Form

© 2026 LBNN – All rights reserved.

Privacy Policy | About Us | Contact

Tiktok Youtube Telegram Instagram Linkedin X-twitter
No Result
View All Result
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • LBNN Blueprints
  • Quizzes
    • Enneagram quiz
  • Fashion Intelligence

© 2023 LBNN - All rights reserved.